OncoViron showed significant anticancer effects on its own and in combination with programmed death 1 (PD-1) antibody and chimeric antigen receptor (CAR) T cells on a variety of implanted solid tumour models, including breast cancer, in immunodeficient, immunocompetent, and humanized mice (15). The gene discussed is PDCD1; the disease is breast carcinoma.